Please use this identifier to cite or link to this item:
Title: High prices of new drugs: we are ready to do whatever it takes
Authors: Capri, Stefano
Issue Date: 2020
Publisher: Università Carlo Cattaneo - LIUC
Bibliographic citation: Capri Stefano (2020), High prices of new drugs: we are ready to do whatever it takes. (Università Cattaneo working papers, 8). Castellanza: Università Carlo Cattaneo - LIUC. E-ISSN 2532-554X. DOI 10.25428/2532-554X/8.
Abstract: Debates over pricing and reimbursement of new and innovative drugs have become increasingly dominated by the excessive high prices and the challenges to the sustainability of the public expenditures. This paper examines the phenomenon of raising prices through the examples of oncology and hepatitis C drugs. In many cases the cost is not related to the benefit promised by the treatment. The costs of R&D of a drug seem to be shrouded in a cloud of mystery, while pharmaceutical companies are still struggling to provide their real R&D costs. The hostage theory is described here in order to explain the lack of instruments which are currently applied to evaluate a new drug. Finally some tentative algoritms are revised, and the need for a combination of cost-effectiveness and budget impact is proposed, trying to combine the private interest with the public interest.
Appears in Collections:Papers

Files in This Item:
File Description SizeFormat 
  Restricted Access
861,42 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.